Table of Contents

January 2016, Volume 23, Number 1

Reviews

    • Stephen J Marx

    Hyperplasia in glands with hormone excess

    Endocr Relat Cancer 23 (1) R1-R14, doi:10.1530/ERC-15-0171 first published on 25 September 2015
    • Casey de Rooy,
    • Mathis Grossmann,
    • Jeffrey D Zajac,
    • and Ada S Cheung

    Targeting muscle signaling pathways to minimize adverse effects of androgen deprivation

    Endocr Relat Cancer 23 (1) R15-R26, doi:10.1530/ERC-15-0232 first published on 2 October 2015
    • Krystallenia I Alexandraki,
    • Gregory A Kaltsas,
    • Simona Grozinsky-Glasberg,
    • Eleftherios Chatzellis,
    • and Ashley B Grossman

    Appendiceal neuroendocrine neoplasms: diagnosis and management

    Endocr Relat Cancer 23 (1) R27-R41, doi:10.1530/ERC-15-0310 first published on 19 October 2015
    • S G Creemers,
    • L J Hofland,
    • E Korpershoek,
    • G J H Franssen,
    • F J van Kemenade,
    • W W de Herder,
    • and R A Feelders

    Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

    Endocr Relat Cancer 23 (1) R43-R69, doi:10.1530/ERC-15-0452 first published on 16 October 2015

Research

    • Arvind Thakkar,
    • Ahmed Aljameeli,
    • Shibu Thomas,
    • and Girish V Shah

    A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells

    Endocr Relat Cancer 23 (1) 1-14, doi:10.1530/ERC-15-0425 first published on 2 October 2015
    • Sisi Liu,
    • Emmanouil Saloustros,
    • Annabel Berthon,
    • Matthew F Starost,
    • Isabelle Sahut-Barnola,
    • Paraskevi Salpea,
    • Eva Szarek,
    • Fabio R Faucz,
    • Antoine Martinez,
    • and Constantine A Stratakis

    Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia

    Endocr Relat Cancer 23 (1) 15-25, doi:10.1530/ERC-15-0472 first published on 5 October 2015
    • Seo Ki Kim,
    • Jung-Woo Woo,
    • Jun Ho Lee,
    • Inhye Park,
    • Jun-Ho Choe,
    • Jung-Han Kim,
    • and Jee Soo Kim

    Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma

    Endocr Relat Cancer 23 (1) 27-34, doi:10.1530/ERC-15-0408
    • Jan Kroon,
    • Martin Puhr,
    • Jeroen T Buijs,
    • Geertje van der Horst,
    • Daniëlle M Hemmer,
    • Koen A Marijt,
    • Ming S Hwang,
    • Motasim Masood,
    • Stefan Grimm,
    • Gert Storm,
    • Josbert M Metselaar,
    • Onno C Meijer,
    • Zoran Culig,
    • and Gabri van der Pluijm

    Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

    Endocr Relat Cancer 23 (1) 35-45, doi:10.1530/ERC-15-0343 first published on 19 October 2015
    OPEN ACCESS ARTICLE
    • Gabriela Franco Mourão,
    • Pedro Weslley Rosario,
    • and Maria Regina Calsolari

    Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation

    Endocr Relat Cancer 23 (1) 47-52, doi:10.1530/ERC-15-0458 first published on 26 October 2015
    • Jeong Won Park,
    • Cho Rong Han,
    • Li Zhao,
    • Mark C Willingham,
    • and Sheue-yann Cheng

    Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model

    Endocr Relat Cancer 23 (1) 53-63, doi:10.1530/ERC-15-0417 first published on 9 November 2015

Acknowledgement

|

This Issue

January 2016; 23 (1)
Cover
  1. Reviews
  2. Research
  3. Acknowledgement

Find articles in this issue containing these words:

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most